1,25(OH)2 vitamin D3 inhibits parathyroid cell proliferation in experimental uremia
- 1 April 1989
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 35 (4) , 1049-1056
- https://doi.org/10.1038/ki.1989.89
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Hyperparathyroidism and abnormal calcitriol metabolism in the spontaneously hypertensive rat.Hypertension, 1989
- Effect of 1,25-dihydroxyvitamin D3 on cytosolic calcium in dispersed parathyroid cellsKidney International, 1988
- Diminished parathyroid 1,25(OH)2D3 receptors in experimental uremiaKidney International, 1987
- Reduced Binding of [3H]l,25-Dihydroxyvitamin D3in the Parathyroid Glands of Patients with Renal FailureNew England Journal of Medicine, 1987
- Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat.Journal of Clinical Investigation, 1986
- Stereological estimation of the volume‐weighted mean volume of arbitrary particles observed on random sections*Journal of Microscopy, 1985
- Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.Journal of Clinical Investigation, 1984
- 1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells.The Journal of cell biology, 1984
- The Importance of Circulating 1,25-Dihydroxyvitamin D in the Pathogenesis of Hypercalciuria and Renal-Stone Formation in Primary HyperparathyroidismNew England Journal of Medicine, 1980
- Parathyroid function in human vitamin D deficiency and vitamin D deficiency in primary hyperparathyroidismThe American Journal of Medicine, 1974